The Patent Finder

Maintenance fees coming due

Novartis AG

239 maintenance fees come due in the 12 months from Nov 16, 2026, the next on Nov 16, 2026. Unpaid by May 17, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5 and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the six month grace period that follows.
PatentTitleHolderStatusFee dueLapses if unpaidExpiresConfidence
US 11,648,253Thienopyrimidinone Nmda Receptor Modulators and Uses Thereof
In force
Fee due Nov 16, 2026
Lapses if unpaid May 17, 2027
 · Medium confidence
Novartis AGIn forceNov 16, 2026May 17, 2027Medium confidence
US 11,654,144Crystalline Forms of 5-Bromo-2,6-DI(1H-PYRAZOL-1-YL)PYRIMIDIN-4-Amine and New Salts
In force
Fee due Nov 23, 2026
Lapses if unpaid May 24, 2027
 · High confidence
Novartis AGIn forceNov 23, 2026May 24, 2027High confidence
US 9,045,470Compounds and Compositions as TLR Activity Modulators
In force
Fee due Dec 2, 2026
Lapses if unpaid Jun 2, 2027
 · High confidence
Novartis AGIn forceDec 2, 2026Jun 2, 2027High confidence
US 9,045,546Molecules And Methods For Modulating TMEM16A Activities
In force
Fee due Dec 2, 2026
Lapses if unpaid Jun 2, 2027
 · High confidence
Novartis AGIn forceDec 2, 2026Jun 2, 2027High confidence
US 10,308,628Heterocyclic Compounds and Methods for Their Use
In force
Fee due Dec 4, 2026
Lapses if unpaid Jun 4, 2027
 · High confidence
Novartis AGIn forceDec 4, 2026Jun 4, 2027High confidence
US 10,308,660Compounds and Compositions for Inhibiting the Activity of SHP2
In force
Fee due Dec 4, 2026
Lapses if unpaid Jun 4, 2027
 · High confidence
Novartis AGIn forceDec 4, 2026Jun 4, 2027High confidence
US 10,308,717TREATMENT OF CANCER USING HUMANIZED ANTI-EGFRvIII CHIMERIC ANTIGEN RECEPTOR
In force
Fee due Dec 4, 2026
Lapses if unpaid Jun 4, 2027
 · High confidence
Novartis AGIn forceDec 4, 2026Jun 4, 2027High confidence
US 11,667,613Antiviral Pyrazolopyridinone Compounds
In force
Fee due Dec 6, 2026
Lapses if unpaid Jun 7, 2027
 · High confidence
Novartis AGIn forceDec 6, 2026Jun 7, 2027High confidence
US 11,667,691Treatment of Cancer Using Chimeric CD3 Receptor Proteins
In force
Fee due Dec 6, 2026
Lapses if unpaid Jun 7, 2027
 · High confidence
Novartis AG and The Trustees of the University of PennsylvaniaIn forceDec 6, 2026Jun 7, 2027High confidence
US 9,050,267Dry powder formulations of particles that contain two or more active ingredients for treating obstructive or inflammatory airways diseases
In force
Fee due Dec 9, 2026
Lapses if unpaid Jun 9, 2027
 · High confidence
Novartis AGIn forceDec 9, 2026Jun 9, 2027High confidence
229 more maintenance fees coming due in the 12 months from Nov 16, 2026 · Pro
10 of 239 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Upgrade to Pro
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited